• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchFaeth Therapeutics
    Picture of Faeth Therapeutics logo

    FTH — Faeth Therapeutics News Story

    $20.100.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $519.39m
    • Enterprise Value
      $332.95m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • FTH Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    FTH Dividends
    All News

    NASDAQ RESUMED AT 09:44 AM

    Picture of Faeth Therapeutics logoFaeth Therapeutics
    18/02/2026 14:44
    NASDAQ RESUMED  SNSE.O  AT 09:44 AM
    

    Recent news on Faeth Therapeutics

    See all news
    • U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike

      17/08/2026 18:40
    • U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies

      17/08/2026 16:52
    • Faeth Therapeutics rises after FDA grants fast-track status for cancer drug

      17/08/2026 13:18
    • Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer

      17/08/2026 12:31
    • Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments

      14/08/2026 13:45

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.